The emergence of AntibodyPlus: the future trend of antibody-based therapeutics

Abstract To date, close to 100 canonical monoclonal antibody drugs have been approved by the FDA; furthermore, a number of antibody-derived therapeutics in nontraditional formats have reached late development stages and the market, and many more are being evaluated in early-stage development. To bet...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antibody Therapeutics 2022-10, Vol.5 (4), p.280-287
Hauptverfasser: Zhu, Yong, Wang, Shawn Shouye, Zhou, Zhaohui Sunny, Ho, Mitchell
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!